Clinical and research diagnostic criteria for Alzheimer's disease.

In contrast with the previous criteria published in 1984 by the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association, the new criteria proposed in 2007 incorporated in the diagnostic framework the use of biomarkers that are able to assess the underlying pathophysiologic mechanism. The combination of clinical and biologic approaches makes a diagnosis of Alzheimer's disease possible before the dementia stage. The core clinical criteria continue to be the cornerstone of the diagnosis in clinical practice, but biomarker evidence is expected to enhance the specificity for the diagnosis of Alzheimer's disease.
AuthorsMarie Sarazin, Leonardo Cruz de Souza, Stéphane Lehéricy, Bruno Dubois
JournalNeuroimaging clinics of North America (Neuroimaging Clin N Am) Vol. 22 Issue 1 Pg. 23-32,viii (Feb 2012) ISSN: 1557-9867 [Electronic] United States
PMID22284731 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
  • Alzheimer Disease (classification, diagnosis)
  • Biomedical Research (standards)
  • Clinical Medicine (standards)
  • Humans
  • Neuroimaging (standards)
  • Practice Guidelines as Topic
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: